Company / EPS (Basic)
MEDICINOVA INC EPS (Basic) History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.23
FY2025
5-year range
-$0.29 / -$0.17
FY2021-FY2025
Trend
-35.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.29 to $-0.23 over the past 2 years.
Based on SEC 10-K filings.
-0.23 in FY2025.
Improved from $-0.29 to $-0.23 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 35.3% year-over-year.
- Peak eps (basic) was recorded in FY2013.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.23 | -35.3% |
| FY2024 | -$0.17 | +41.4% |
| FY2023 | -$0.29 | -38.1% |
| FY2022 | -$0.21 | - |
| FY2021 | - | - |
| FY2014 | - | - |
| FY2013 | -$0.14 | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026